Monique van Scherpenzeel
Together with my business partners for specialized data analysis and my husband with his company CastellIT, who takes care of the data-storage, report automation and ICT infrastructure, we are able to offer you a variety of analyses.
About GlycoMScan
The company started in April 2018 with preclinical analyses of nucleotide sugars for a start-up pharmaceutical company in San Francisco (US), to aim for the first medicine for the rare disorder PMM2-CDG, a congenital disorder of glycosylation.
News
I am specialized in analyses of glycosylation and the building blocks thereof, the nucleotide sugars and phosphorylated sugars from intracellular metabolism,” says Monique van Scherpenzeel, GlycoMScan’s CEO.
About Monique
I switched my career from assistant professor in Clinical Glycomics at Radboud UMC to start my own business, which arose from the research of my personal NWO-Veni grant.
About Monique
About GlycoMScan
GlycoMScan provides contract research and analytical services for pharma, life sciences companies and academia. We are specialized in mass spectrometry and have a background in protein and glycosylation analyses, especially in the building blocks thereof which are present in the intracellular metabolism. More about GlycoMScan
